Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 5/2018

01-05-2018 | Original Article

Incidence and treatment of metachronous gastric cancer after proximal gastrectomy

Authors: Yoshinori Iwata, Seiji Ito, Kazunari Misawa, Yuichi Ito, Koji Komori, Tetsuya Abe, Yasuhiro Shimizu, Masahiro Tajika, Yasumasa Niwa, Kazuhiro Yoshida, Taira Kinoshita

Published in: Surgery Today | Issue 5/2018

Login to get access

Abstract

Background and purpose

Proximal gastrectomy (PG) is a widely accepted function-preserving surgical procedure; however, the incidence and treatment of metachronous gastric cancer (MGC) after PG have been the subject of a number of reports.

Methods

We collected data from 1576 consecutive patients who underwent gastrectomy for gastric cancer between January, 2003 and December, 2010, and analyzed the outcomes of 671 patients treated with PG or distal gastrectomy (DG) for cT1N0 disease. We also discuss the treatments for MGC.

Results

MGC was diagnosed within a median follow-up of 52.8 months after PG and DG in six (6.6%) and nine (1.8%) patients, respectively. The cumulative prevalence of MGC after PG was significantly higher than that after DG; P = 0.005. Univariate and multivariate analysis revealed male sex and PG as significant risk factors for MGC (P = 0.014 and P = 0.026, respectively). Five of the six patients who underwent PG were treated by endoscopic submucosal dissection.

Conclusions

The incidence of MGC after PG was significantly higher than that after DG. However, most of the MGCs that developed after PG could be treated by endoscopic submucosal dissection.
Literature
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–86.CrossRef
2.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010. (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
3.
Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery. 1998;123:127–30.CrossRefPubMed
4.
Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg. 2003;90:850–3.CrossRefPubMed
5.
Nozaki I, Kurita A, Nasu J, Kubo Y, Aogi K, Tanada M, et al. Higher incidence of gastric remnant cancer after proximal than distal gastrectomy. Hepatogastroenterology. 2007;54:1604–8.PubMed
6.
Nunobe S, Ohyama S, Miyata S, Matsuura M, Hiki N, Fukunaga T, et al. Incidence of gastric cancer in the remnant stomach after proximal gastrectomy. Hepatogastroenterology. 2008;55:1855–8.PubMed
7.
Ohyama S, Tokunaga M, Hiki N, Fukunaga T, Fujisaki J, Seto Y, et al. A clinicopathological study of gastric stump carcinoma following proximal gastrectomy. Gastric cancer. 2009;12:88–94.CrossRefPubMed
8.
Hirasaki S, Kanzaki H, Matsubara M, Fujita K, Matsumura S, Suzuki S. Treatment of gastric remnant cancer post distal gastrectomy by endoscopic submucosal dissection using an insulation-tipped diathermic knife. World J Gastroenterol. 2008;14:2550–5.CrossRefPubMedPubMedCentral
9.
Lee JY, Choi IJ, Cho SJ, Kim CG, Kook MC, Lee JH, et al. Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc. 2010;24:1360–6.CrossRefPubMed
10.
11.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 3rd English ed. Gastric Cancer. 2011;14:101–12.CrossRef
12.
Kosaka T, Miwa K, Yonemura Y, Urade M, Ishida T, Takegawa S, et al. A clinicopathologic study on multiple gastric cancers with special reference to distal gastrectomy. Cancer. 1990;65:2602–5.CrossRefPubMed
13.
Moreaux J, Mathey P, Msika S. Gastric adenocarcinoma in the gastric stump after partial gastrectomy. Hepatogastroenterology. 1991;38:517–21.PubMed
14.
Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, et al. Clinicopathological characteristics of remnant gastric cancer after a distal gastrectomy. J Gastrointest Surg. 2010;14:277–81.CrossRefPubMed
15.
Komatsu S, Ichikawa D, Okamoto K, Ikoma D, Tsujiura M, Nishimura Y, et al. Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy. World J Gastroenterol. 2012;18:2832–6.CrossRefPubMedPubMedCentral
16.
Takeno S, Noguchi T, Kimura Y, Fujiwara S, Kubo N, Kawahara K. Early and late gastric cancer arising in the remnant stomach after distal gastrectomy. Eur J Surg Oncol. 2006;32:1191–4.CrossRefPubMed
17.
Ahn HS, Kim JW, Yoo MW, Park do J, Lee HJ, Lee KU, et al. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol. 2008;15:1632–9.CrossRefPubMed
18.
19.
Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg. 2007;94:92–5.CrossRefPubMed
20.
Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:51–66.CrossRefPubMed
21.
Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Nakajima T, et al. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy. 2015;47:1113–8.CrossRefPubMed
22.
Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther. 1999;13:851–6.CrossRefPubMed
23.
Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169–79.CrossRefPubMed
24.
Fukuhara K, Osugi H, Takada N, Takemura M, Lee S, Taguchi S, et al. Duodenogastric reflux eradicates Helicobacter pylori after distal gastrectomy. Hepatogastroenterology. 2004;51:1548–50.PubMed
25.
Abe H, Murakami K, Satoh S, Sato R, Kodama M, Arita T. Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy. J Gastroenterol. 2005;40:563–9.CrossRefPubMed
26.
Nabeshima K, Ogoshi K. Relationship between Helicobacter pylori and histological changes in the gastric remnant after subtotal gastrectomy. Tokai J Exp Clin Med. 2011;36:139–43.PubMed
27.
Sillakivi T, Suumann J, Kirsimägi U, Peetsalu A. Plasma levels of gastric biomarkers in patients after bariatric surgery: biomarkers after bariatric surgery. Hepatogastroenterology. 2013;60:2129–32.PubMed
28.
Grong E, Arbo IB, Thu OK, Kuhry E, Kulseng B, Mårvik R. The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats. Surg Endosc. 2015;29:723–33.CrossRefPubMed
29.
Helge LW, Liv S, Patricia M. Gastrin and gastric cancer. Front Endocrinol. 2017;8:1–7.
30.
Smith JP, Shih AH, Wotring MG, et al. Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma. Int J Oncol. 1998;12:411–9.PubMed
31.
32.
Jang MY, Cho JW, Oh WG, Ko SJ, Han SH, Baek HK, et al. Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection. Korean J Intern Med. 2013;28:687–93.CrossRefPubMedPubMedCentral
33.
Mori G, Nakajima T, Asada K, Shimazu T, Yamamichi N, Maekita T, et al. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan. Gastric Cancer. 2016;19:911–8.CrossRefPubMed
34.
Nozaki I, Nasu J, Kubo Y, Tanada M, Nishimura R, Kurita A. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg. 2010;34:1548–54.CrossRefPubMed
35.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.PubMed
36.
37.
Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol. 2006;163:629–37.CrossRefPubMed
38.
Sasako M, Maruyama K, Kinoshita T, Okabayashi K. Surgical treatment of carcinoma of the gastric stump. Br J Surg. 1991;78:822–4.CrossRefPubMed
39.
Takeda J, Toyonaga A, Koufuji K, Kodama I, Aoyagi K, Yano S, et al. Early gastric cancer in the remnant stomach. Hepatogastroenterology. 1998;45:1907–11.PubMed
40.
Hoteya S, Iizuka T, Kikuchi D, Yahagi N. Clinical advantages of endoscopic submucosal dissection for gastric cancers in remnant stomach surpass conventional endoscopic mucosal resection. Dig Endosc. 2010;22:17–20.CrossRefPubMed
41.
Nonaka S, Oda I, Makazu M, Haruyama S, Abe S, Suzuki H, et al. Endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy. Gastrointest Endosc. 2013;78:63–72.CrossRefPubMed
42.
Kim SM. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy. Ann Gastroenterol. 2014;27:85–6.PubMedPubMedCentral
43.
Morgagni P, Gardini A, Marrelli D, Vittimberga G, Marchet A, de Manzoni G, et al. Gastric stump carcinoma after distal subtotal gastrectomy for early gastric cancer: experience of 541 patients with long-term follow-up. Am J Surg. 2015;209:1063–8.CrossRefPubMed
44.
Ortiz J, Ragunath K. Long-term survival after endoscopic resection for early gastric cancer in the remnant stomach: comparison with radical surgery. Ann Gastroenterol. 2015;28:1–2.PubMedPubMedCentral
45.
Yamashina T, Uedo N, Dainaka K, Aoi K, Matsuura N, Ito T, et al. Long-term survival after endoscopic resection for early gastric cancer in the remnant stomach: comparison with radical surgery. Ann Gastroenterol. 2015;28:66–71.PubMedPubMedCentral
46.
Hosokawa O, Kaizaki Y, Watanabe K, Hattori M, Douden K, Hayashi H, et al. Endoscopic surveillance for gastric remnant cancer after early cancer surgery. Endoscopy. 2002;34:469–73.CrossRefPubMed
47.
Greene FL. Management of gastric remnant carcinoma based on the results of a 15-year endoscopic screening program. Ann Surg. 1996;223:701–6; (discussion 6–8).CrossRefPubMedPubMedCentral
Metadata
Title
Incidence and treatment of metachronous gastric cancer after proximal gastrectomy
Authors
Yoshinori Iwata
Seiji Ito
Kazunari Misawa
Yuichi Ito
Koji Komori
Tetsuya Abe
Yasuhiro Shimizu
Masahiro Tajika
Yasumasa Niwa
Kazuhiro Yoshida
Taira Kinoshita
Publication date
01-05-2018
Publisher
Springer Singapore
Published in
Surgery Today / Issue 5/2018
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-018-1632-0

Other articles of this Issue 5/2018

Surgery Today 5/2018 Go to the issue

Letter to the Editor

Frequency of cerebral infarction after pulmonary resection: a multicenter, retrospective study in Japan

Original Article

Laparoscopic surgery for locally advanced T4 colon cancer: the long-term outcomes and prognostic factors

Original Article

Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer

Original Article

Development of a new surgical sheet containing both silk fibroin and thermoplastic polyurethane for cardiovascular surgery

Original Article

Predictors of the need for pacemaker implantation after the Cox maze IV procedure for atrial fibrillation

How To Do It

Segmental clamp and distal perfusion technique for reducing myocardial ischemia during coronary onlay grafting on a beating heart